Alembic Pharmaceuticals Limited has informed the Exchange regarding Change in Auditors of the company.
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals informed the stock exchanges that shareholders at the 15th Annual General Meeting held on 5th August 2025 approved the appointment of two new auditors. M/s. KKC & Associates LLP (formerly Khimji Kunverji & Co. LLP), a peer-reviewed firm established in 1936 with 200+ members, has been appointed as Statutory Auditor for a 5-year term starting 5th August 2025 until the AGM for FY 2029-30, replacing M/s. K.C. Mehta & Co. LLP upon completion of their term. Additionally, M/s. Samdani Shah & Kabra, a peer-reviewed firm of Practising Company Secretaries, has been appointed as Secretarial Auditor for a 5-year term covering FY 2025-26 to FY 2029-30. This is a routine, planned rotation of auditors rather than a sudden or contentious change.
This is a routine, regulatory-compliant auditor rotation following completion of the previous auditor's term, with no governance red flags. Stock price impact is expected to be neutral as auditor changes at the end of tenure are standard practice for listed companies.